Skip to main content

REGN

REGENERON PHARMACEUTICALS, INC.
Sector
Health Care
Industry
Biotechnology
Last price
$621.41
As of

Active signals for REGN

Top institutional holders of REGN (13F)

FundMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LP$627.6M0.51%+188.9%
TWO SIGMA INVESTMENTS, LP$264.2M0.39%,
TWO SIGMA INVESTMENTS, LP$217M0.31%-40.2%
CITADEL ADVISORS LLC$211.5M0.03%+66.4%
RENAISSANCE TECHNOLOGIES LLC$154.7M0.20%,
Bridgewater Associates, LP$132.3M0.52%,
D. E. Shaw & Co., Inc.$120M0.07%+21.3%
Point72 Asset Management, L.P.$113.3M0.19%,
Point72 Asset Management, L.P.$111.1M0.14%>1000%
CITADEL ADVISORS LLC$92.6M0.01%,
D. E. Shaw & Co., Inc.$72M0.04%,
Bridgewater Associates, LP$56.1M0.20%-69.1%
RENAISSANCE TECHNOLOGIES LLC$51.6M0.08%+635.5%
MILLENNIUM MANAGEMENT LLC$30.1M0.01%+245.1%
MILLENNIUM MANAGEMENT LLC$21.8M0.01%-27.7%
D. E. Shaw & Co., Inc.$17.6M0.01%-85.4%
Bridgewater Associates, LP$17.6M0.08%-68.8%
RENAISSANCE TECHNOLOGIES LLC$7M0.01%-96.7%
MILLENNIUM MANAGEMENT LLC$6.4M0.00%,
Point72 Asset Management, L.P.$695K0.00%-99.6%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, REGN

Related tickers in Health Care

See more REGN signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track REGN in your watchlist and get notified the moment a new signal fires.

Track REGN on Kresmion →